Search
Search Results
-
Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania
BackgroundMost cervical cancer patients in develo** countries seek care in health facilities with an advanced disease, often characterized by...
-
Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis
BackgroundThe watch-and-wait (WW) strategy is a potential option for patients with rectal cancer who obtain a complete clinic response after...
-
Cost-utility analysis of different venous access devices in breast cancer patients: a decision-based analysis model
BackgroundVenous access devices commonly used in clinical practice for long-term chemotherapy of breast cancer include central venous catheters...
-
Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis
BackgroundGastric cancer patients with peritoneal carcinomatosis (PC) have a poor prognosis, with a median overall survival of 10 months when treated...
-
Anastrozole for the prevention of breast cancer in high-risk postmenopausal women: cost-effectiveness analysis in the UK and the USA
PurposeThe effectiveness of anastrozole for breast cancer prevention has been demonstrated. The objective of this study was to evaluate the...
-
A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe
BackgroundThis study aimed to conduct a systematic review of the cost-effectiveness studies of interventions to increase cervical cancer screening...
-
Cost-Effectiveness Analysis of Digital Breast Tomosynthesis and Mammography in Breast Cancer Screening: A Markov Modeling Study
BackgroundMammography (MG) has demonstrated its effectiveness in diminishing mortality and advanced-stage breast cancer incidences in breast...
-
Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy
ObjectiveTo provide up-to-date and comprehensive US data tables to estimate future net resource use, including nonlabor market production, and...
-
Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand
IntroductionCervical cancer ranks as the third most prevalent cancer among women in Thailand. However, the effectiveness of cervical cancer screening...
-
Cost consequences of unscheduled emergency admissions in cancer patients in the last year of life
ObjectivesCancer is a leading cause of death. This paper examines the utilisation of unscheduled emergency end-of-life healthcare and estimates...
-
Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer
BackgroundWire localisation (WL) is the “gold standard” localisation technique for wide local excision (WLE) of non-palpable breast lesions but has...
-
Optimizing resource allocation: Cost-effectiveness of specified D-dimer cut-offs in cancer patients with suspected venous thromboembolism
An accurate diagnosis of venous thromboembolism (VTE) is crucial, given the potential for high mortality in undetected cases. Strategic D-dimer...
-
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model
BackgroundBreast cancer represents the most prevalent cancer among Swedish women. Although considerable research has investigated the...
-
Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?
ObjectivesAccurate risk stratification of patients with stage II and III colorectal cancer (CRC) prior to treatment selection enables limited health...
-
Cost-effectiveness of pembrolizumab versus chemotherapy in patients with platinum-pretreated, recurrent or metastatic nasopharyngeal cancer
BackgroundProgrammed cell death protein 1 (PD-1) monoclonal antibody, pembrolizumab, is a promising drug for platinum-pretreated, recurrent or...
-
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
PurposeClinical practice guidelines recommend the use of all approved granulocyte colony-stimulating factors (G-CSFs), including filgrastim and...
-
Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran
IntroductionIn recent years, enzalutamide and abiraterone have been widely used as treatments for metastatic castration-resistant prostate cancer...
-
An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada
BackgroundDetermining whether multi-cancer early detection (MCED) tests are cost effective is important in deciding whether they should be included...
-
Pricing and cost-saving potential for deep-learning computer-aided lung nodule detection software in CT lung cancer screening
ObjectiveAn increasing number of commercial deep learning computer-aided detection (DL-CAD) systems are available but their cost-saving potential is...
-
Cost–utility analysis of trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer in Chinese setting
PurposeTrastuzumab deruxtecan (T-DXd) expressed substantial improvement in the progression-free survival and overall survival contrasted with...
